Summary
The main objective is to analyze the impact of dietary hypocaloric interventions based on their capacity to generate ketone bodies in different degrees of intensity: using Intermittent fasting, KetoDiet in comparison with the classical MedDiet, in individuals with obesity, and their influences on the gut microbiota, resistome, host metabolism, and the possible genetic and epigenetics links. We aim to contribute with the advance in the development of a precision medicine approach in obesity to decrease the prevalence of obesity and its associated comorbidities, and to evaluate the impact of dietary interventions as an alternative approach to antimicrobial resistance.
To achieve our goal, we will study in a randomized cross-over group of individuals with obesity: A) Analyse the effect of dietary interventions (MedDiet, intermittent fasting (IF) and KetoDiet) on the gut microbiota composition and the relationship with anthropometrics, metabolic, inflammatory and epigenetics driven factors at short term (1 month) B) Analyse the effect of dietary interventions (MedDiet, IF, KetoDiet) on the gut microbiota composition and the relationship with epigenetics factors at medium-term(3 months) C) Evaluate the impact of the gut microbiota targeted dietary interventions (MedDiet, IF and KetoDiet) at short- and medium-term on the gut resistome and relate it with the inflammatory milieu of the host.
Our results will help to improve the treatment of metabolic diseases associated to obesity using a precision medicine approach based on the influence of diet interventions on the gut microbiota, gut resistome, host response and environmental factors. The outcome of this project will have an impact in the health sector by improving mental health and physical health of all overweight and obese individuals, in the economy sector by reducing the need of surgical approaches to achieve weight loss, reducing the risk of development obesity-related complications and overuse of antimicrobials.
To achieve our goal, we will study in a randomized cross-over group of individuals with obesity: A) Analyse the effect of dietary interventions (MedDiet, intermittent fasting (IF) and KetoDiet) on the gut microbiota composition and the relationship with anthropometrics, metabolic, inflammatory and epigenetics driven factors at short term (1 month) B) Analyse the effect of dietary interventions (MedDiet, IF, KetoDiet) on the gut microbiota composition and the relationship with epigenetics factors at medium-term(3 months) C) Evaluate the impact of the gut microbiota targeted dietary interventions (MedDiet, IF and KetoDiet) at short- and medium-term on the gut resistome and relate it with the inflammatory milieu of the host.
Our results will help to improve the treatment of metabolic diseases associated to obesity using a precision medicine approach based on the influence of diet interventions on the gut microbiota, gut resistome, host response and environmental factors. The outcome of this project will have an impact in the health sector by improving mental health and physical health of all overweight and obese individuals, in the economy sector by reducing the need of surgical approaches to achieve weight loss, reducing the risk of development obesity-related complications and overuse of antimicrobials.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101151843 |
| Start date: | 06-01-2025 |
| End date: | 05-01-2027 |
| Total budget - Public funding: | - 181 152,00 Euro |
Cordis data
Original description
The main objective is to analyze the impact of dietary hypocaloric interventions based on their capacity to generate ketone bodies in different degrees of intensity: using Intermittent fasting, KetoDiet in comparison with the classical MedDiet, in individuals with obesity, and their influences on the gut microbiota, resistome, host metabolism, and the possible genetic and epigenetics links. We aim to contribute with the advance in the development of a precision medicine approach in obesity to decrease the prevalence of obesity and its associated comorbidities, and to evaluate the impact of dietary interventions as an alternative approach to antimicrobial resistance.To achieve our goal, we will study in a randomized cross-over group of individuals with obesity: A) Analyse the effect of dietary interventions (MedDiet, intermittent fasting (IF) and KetoDiet) on the gut microbiota composition and the relationship with anthropometrics, metabolic, inflammatory and epigenetics driven factors at short term (1 month) B) Analyse the effect of dietary interventions (MedDiet, IF, KetoDiet) on the gut microbiota composition and the relationship with epigenetics factors at medium-term(3 months) C) Evaluate the impact of the gut microbiota targeted dietary interventions (MedDiet, IF and KetoDiet) at short- and medium-term on the gut resistome and relate it with the inflammatory milieu of the host.
Our results will help to improve the treatment of metabolic diseases associated to obesity using a precision medicine approach based on the influence of diet interventions on the gut microbiota, gut resistome, host response and environmental factors. The outcome of this project will have an impact in the health sector by improving mental health and physical health of all overweight and obese individuals, in the economy sector by reducing the need of surgical approaches to achieve weight loss, reducing the risk of development obesity-related complications and overuse of antimicrobials.
Status
SIGNEDCall topic
HORIZON-MSCA-2023-PF-01-01Update Date
20-11-2024
Images
No images available.
Geographical location(s)
